1、endometrial carcinoma
2、A clinical analysis of endometrial carcinoma
3、Research progress on chemotherapy of endometrial carcinoma;
4、Expressions of Nucleostemin and PCNA in endometrial carcinoma
5、Expression and function of cyclooxygenase-2 in endometrial carcinoma
6、Expression of insulin receptor substrate-1 in endometrial carcinoma
7、Expressions of TGFβ and TGFβR Ⅱ in the tissues of endometrial hyperplasia and endometrial carcinoma
8、A study on cancer′ distribution of hereditary endometrial carcinoma. The clinic and pathologic characters of young women with endometrial carcinoma
9、Value of MRI T_2WI in the assessment of uterine invasion by endometrial carcinoma
10、Value of functional magnetic resonance imaging in preoperative staging of endometrial carcinoma
11、The experiment study of high intensity ultrasound in the ablation endometrial carcinoma in vitro
12、Expressions of Cox-2 and Bcl-2 in endometrial carcinoma tissue
13、Expression and clinical significance of P16 protein and cyclin D1 in endometrial carcinoma
14、Effect of triptorelin acetate on human endometrial carcinoma cell line HEC-1B and expression of C-myc
15、There were2cases of clear cellular adenocarcinoma (1had metastasis)in perimenopause, and2undifferential endometrial carcinoma (all metastasis)in postmenopause.
16、The effect of tamoxifen on the proliferation and the intracellular Ca~(2+) of human endometrial carcinoma cells
17、Clinical prognostic factors influencing the accuracy of dilatation and curettage in diagnosis of tumor grade of endometrial carcinoma
18、The correlation between the expression of transforming growth factor β1 as well as its receptor and the genesis of endometrial carcinoma
19、OBJECTIVE To study the effects of volatileoil, curcumenol, curzerenone and isocurcumenol from Curcuma phaeocaulis Valeton on liver cancer and endometrial carcinoma cell lines.
20、RESULTS and CONCLUSION It shows that volatile oil, curcumenol, curzerenone and isocurcumenol from Curcuma phaeocaulis Valeton can inhibit the proliferation of liver cancer and endometrial carcinoma cells in different concentrations.
